Find News

Filter articles

Applied Filters

Showing 1 to 10 of 626 results

GE Healthcare files patent lawsuit against Bio-Rad


American conglomerate GE Healthcare last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement.

Allele Biotech partners with to develop nanoantibodies


US-based Allele Biotechnology & Pharmaceuticals, a preclinical-stage biopharmaceutical company, has teamed up with a scientific e-commerce marketplace network in efforts to develop nanoantibodies for therapeutic applications.

Boehringer in research collaboration with Domain Therapeutics

Canada, France, Germany04-12-2018

German pharmaceutical company Boehringer Ingelheim has signed a research collaboration and licence agreement with French and Canadian biopharmaceutical business Domain Therapeutics.

NHS to save £300m in biosimilar adalimumab deals


The National Health Service England is set to make record-breaking savings after negotiating deals with five manufacturers of low-cost biosimilar versions of the NHS's most expensive drug.

New policies weakening IP innovation incentives: report


Despite the importance of IP rights to biotech and biopharma innovation, recent decisions and new policies are weakening and reducing the scope of IP-based incentives, according to a report.

Scientists want CRISPR regulation amid reports of foetus gene-editing


Scientists have urged policymakers to implement a regulatory framework governing the use of CRISPR technology in humans, following reports that a Chinese scientist has successfully created ‘edited’ twins.

CRISPR tech market to reach $1.72m by 2023: report


The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.

Life sciences partners join Saul Ewing’s Boston office


Saul Ewing Arnstein & Lehr has strengthened its Boston office with the addition of two life sciences partners from Hamilton, Brook, Smith & Reynolds.

10x Genomics sued over cell research tools


Genome sequencing company 10x Genomics has been accused of infringing 11 patents covering cell research and analysis tools.

Brexit draft deal: a welcome step but more certainty needed, say lawyers

EU, UK16-11-2018

While the pharmaceutical industry has welcomed the draft Withdrawal Agreement for the UK’s departure from the EU, more clarity is still needed, lawyers have told LSIPR.

Showing 1 to 10 of 626 results